sharetrader
  1. #12001
    Member
    Join Date
    Jan 2015
    Posts
    356

    Default

    https://nzx.com/companies/PEB/announcements/264571

    Full Year Results to be Released on 28 May 2015
    3:51pm, 20 May 2015 | GENERAL
    20 May 2015


    FULL YEAR RESULTS TO BE RELEASED ON 28 MAY 2015


    Pacific Edge Limited (NZX:PEB) intends to announce its results for the financial year ended 31 March 2015 on Thursday 28 May 2015, prior to 10am NZST.


    For more information contact:

  2. #12002
    Member
    Join Date
    Mar 2014
    Posts
    269

    Default

    Quote Originally Posted by skid View Post
    Whats that got to do with chooks?
    Here you go Skid. Just for you and Miner...

    https://www.youtube.com/watch?v=ddLOviIZxlA

  3. #12003
    AWOL
    Join Date
    Sep 2012
    Location
    Vacation
    Posts
    2,782

    Default

    Quote Originally Posted by skid View Post
    OMG--Genomic health! That is our worst nightmare (seriously,it may surprise some but, I want this Kiwi co.(PEB) to succeed--but have just gotten frustrated with management and a few of the idealistic posts)--but this we do not need.

    Hopefully it will take a long while to get to market(or maybe it wont be as good?)

    And where was PEB at the AUA annual meeting in New Orleans where this presentation was made?
    Relax, skid.
    10% for PEB, 10% for Genomics maybe, who gets the other 80%?

  4. #12004
    Guru
    Join Date
    Feb 2010
    Posts
    3,809

    Default

    Quote Originally Posted by Tsuba View Post
    Here you go Skid. Just for you and Miner...

    https://www.youtube.com/watch?v=ddLOviIZxlA
    Thats better.....

  5. #12005
    Guru
    Join Date
    Feb 2010
    Posts
    3,809

    Default

    Genomics has been covered relatively well in earlier posts--Geez -if we had them here it would no doubt raise our GDP--not happy with just breast, bowel and prostate cancer tests--greedy b____terds.

  6. #12006
    IMO
    Join Date
    Aug 2010
    Location
    Floating Anchor Shoals
    Posts
    9,742

    Default

    Quote Originally Posted by skid View Post
    Whats that got to do with chooks?
    Even better fit

    Headless Chicken Lives - YouTube

  7. #12007
    Member
    Join Date
    Mar 2014
    Posts
    415

    Default

    Quick question to the brains trust, have you guys read page 61 of MDXhealth last annual report (Feb)? covers issues regarding reimbursement, revenue and when revenue is recognised. Question, could this same situation apply to peb?

    http://mdxhealth.com/financials

    I know DD and Co have done a very impressive job of operating a lean machine, but reading MDXreport where they mention having 60-80 sales reps in five years, do we think Peb are being aggressive enough with only 12or16? Keeping in mind the training time for each rep.

    Sorry if this has already been covered and sorry if some find these questions stupid, but the only stupid question is the one that is not asked.

    Cheers

  8. #12008
    AWOL
    Join Date
    Sep 2012
    Location
    Vacation
    Posts
    2,782

    Default

    Quote Originally Posted by Carpenterjoe View Post
    Quick question to the brains trust, have you guys read page 61 of MDXhealth last annual report (Feb)? covers issues regarding reimbursement, revenue and when revenue is recognised. Question, could this same situation apply to peb?

    http://mdxhealth.com/financials

    I know DD and Co have done a very impressive job of operating a lean machine, but reading MDXreport where they mention having 60-80 sales reps in five years, do we think Peb are being aggressive enough with only 12or16? Keeping in mind the training time for each rep.

    Sorry if this has already been covered and sorry if some find these questions stupid, but the only stupid question is the one that is not asked.

    Cheers
    Have just read page 61 and it seems to have quite a few similarities to PEBs case. PEB have stated that they are processing Medicare patients and it would appear they are not getting paid as yet. If these tests are unrecognised and are therefore not included as receivables and we dont know how many have been done as a proportion of the lab throughput, then we are in the dark until things get sorted. If the MDX case is normal for this scene then it looks as if their revenue is about half of what is due.
    Working backwards from the FY 15 results next week this may give us some rough idea of throughput to revenue ratio and therefore numbers of tests performed. ie if Peb announces 2.0 mill in revenue recognised from sales is there actually 4.0 million altogether giving 8000 odd tests?
    Bit of a long bow to draw but its a big target
    It was always suspected there would be some kind of windfall eventually via Medicare after signup.
    Dont know if MDX are targeting large groups of urologists like PEB. This may account for the bigger sales force if they are going direct to doctors.
    Thanks for pointing page 61 out, it has made things quite a bit clearer for me and probably for others.


    P.S.Seems that the news feeds are hitting overtime. Have had about 5 alerts from various sources, the latest from FierceBiotech. Words getting out, bigtime.
    Last edited by Minerbarejet; 21-05-2015 at 07:43 AM.

  9. #12009
    Guru
    Join Date
    Feb 2010
    Posts
    3,809

    Default

    Quote Originally Posted by Minerbarejet View Post
    Have just read page 61 and it seems to have quite a few similarities to PEBs case. PEB have stated that they are processing Medicare patients and it would appear they are not getting paid as yet. If these tests are unrecognised and are therefore not included as receivables and we dont know how many have been done as a proportion of the lab throughput, then we are in the dark until things get sorted. If the MDX case is normal for this scene then it looks as if their revenue is about half of what is due.
    Working backwards from the FY 15 results next week this may give us some rough idea of throughput to revenue ratio and therefore numbers of tests performed. ie if Peb announces 2.0 mill in revenue recognised from sales is there actually 4.0 million altogether giving 8000 odd tests?
    Bit of a long bow to draw but its a big target
    It was always suspected there would be some kind of windfall eventually via Medicare after signup.
    Dont know if MDX are targeting large groups of urologists like PEB. This may account for the bigger sales force if they are going direct to doctors.
    Thanks for pointing page 61 out, it has made things quite a bit clearer for me and probably for others.


    P.S.Seems that the news feeds are hitting overtime. Have had about 5 alerts from various sources, the latest from FierceBiotech. Words getting out, bigtime.

    Here we go again--googled Fierce Biotek----no sign of PEB Whats the point of getting in a number of publications if you are stuck somewhere in a hidden cob web filled corner that no one sees? (your system of alerts is flawed in that sense if you dont carry on and see if it is there to see for the customer(whoever that is)---Heres a little test-

    On May 28th someones reputation is on the line --either PEB or Edison

    Even if you decide to project that thier revenues are double @4% of their target (100mil) Is that good enough for year 3 with some big players coming on at pace ?(thats not just heresay any more with genomic throwing their hat in --Is now a race.


    PS--4am?--dont you sleep?
    Last edited by skid; 21-05-2015 at 09:18 AM.

  10. #12010
    AWOL
    Join Date
    Sep 2012
    Location
    Vacation
    Posts
    2,782

    Default

    Quote Originally Posted by skid View Post
    Here we go again--googled Fierce Biotek----no sign of PEB Whats the point of getting in a number of publications if you are stuck somewhere in a hidden cob web filled corner that no one sees? (your system of alerts is flawed in that sense if you dont carry on and see if it is there to see for the customer(whoever that is)---Heres a little test-

    On May 28th someones reputation is on the line --either PEB or Edison

    Even if you decide to project that thier revenues are double @4% of their target (100mil) Is that good enough for year 3 with some big players coming on at pace ?(thats not just heresay any more with genomic throwing their hat in --Is now a race.


    PS--4am?--dont you sleep?
    Sorry, Skid, it wasnt biotech but Diagnostics. Here is the link.
    http://www.fiercediagnostics.com/pre...-bladder-cance

    Much the same as the others.
    cxbladder detect launched in July 2013
    How do you figure year 3? It hasnt been available 2 years yet in the States
    Try and forget they ever mentioned 100 million, that is not the defining moment.
    That moment is where they make a profit, however minor.
    Genomics hat consists of a bladder cancer monitor,( not detect, triage or predict) and wont be out until 2016
    Still has to be better than CxBladder to be a threat.
    The only race is the human race that all these companies are trying to help.
    Rust never sleeps.
    Last edited by Minerbarejet; 21-05-2015 at 10:12 AM.

Tags for this Thread

Bookmarks

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •